Stockscreener 앱 받기
204.00
0.51%
-1.04
시간 외 거래:
205.80
1.80
+0.88%
전일 마감가:
$205.04
열려 있는:
$204.68
하루 거래량:
2.16M
Relative Volume:
0.95
시가총액:
$43.51B
수익:
$447.02M
순이익/손실:
$-1.18B
주가수익비율:
-33.00
EPS:
-6.1812
순현금흐름:
$-906.14M
1주 성능:
-1.81%
1개월 성능:
+9.16%
6개월 성능:
+180.45%
1년 성능:
+170.81%
1일 변동 폭
$203.15
$206.56
1주일 범위
$202.68
$212.75
52주 변동 폭
$60.40
$212.75
Insmed Inc Stock (INSM) Company Profile
명칭
Insmed Inc
전화
908-977-9900
주소
700 US HIGHWAY 202/206, BRIDGEWATER, NJ
INSM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
INSM
Insmed Inc
|
204.00 | 43.73B | 447.02M | -1.18B | -906.14M | -6.1812 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.48 | 116.04B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
718.36 | 75.97B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
458.12 | 61.48B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
901.17 | 56.40B | 3.06B | 1.28B | 447.35M | 19.67 |
Insmed Inc Stock (INSM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-28 | 재개 | Cantor Fitzgerald | Overweight |
| 2025-10-20 | 개시 | Wells Fargo | Overweight |
| 2025-08-20 | 개시 | William Blair | Outperform |
| 2025-08-13 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2025-05-13 | 개시 | Jefferies | Buy |
| 2025-02-25 | 개시 | RBC Capital Mkts | Outperform |
| 2024-04-23 | 개시 | Truist | Buy |
| 2024-02-15 | 개시 | Wolfe Research | Outperform |
| 2023-12-08 | 개시 | Wells Fargo | Overweight |
| 2023-11-20 | 재개 | JP Morgan | Overweight |
| 2023-07-26 | 개시 | Guggenheim | Buy |
| 2022-12-09 | 개시 | Mizuho | Buy |
| 2022-12-07 | 개시 | Barclays | Overweight |
| 2022-11-18 | 개시 | BofA Securities | Buy |
| 2022-04-27 | 개시 | Goldman | Buy |
| 2021-12-06 | 개시 | JP Morgan | Overweight |
| 2021-10-19 | 재개 | Monness Crespi & Hardt | Buy |
| 2021-10-19 | 재개 | Morgan Stanley | Overweight |
| 2021-10-08 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-04-26 | 재개 | Credit Suisse | Outperform |
| 2020-12-17 | 개시 | Berenberg | Buy |
| 2020-10-12 | 재개 | Stifel | Buy |
| 2019-09-03 | 개시 | Goldman | Buy |
| 2019-04-09 | 재확인 | H.C. Wainwright | Buy |
| 2019-02-15 | 업그레이드 | JMP Securities | Mkt Perform → Mkt Outperform |
| 2019-01-17 | 업그레이드 | Goldman | Neutral → Buy |
| 2019-01-02 | 개시 | Canaccord Genuity | Buy |
| 2018-08-06 | 다운그레이드 | JMP Securities | Mkt Outperform → Mkt Perform |
| 2018-07-23 | 개시 | Goldman | Neutral |
| 2018-04-23 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2018-03-21 | 개시 | Morgan Stanley | Overweight |
| 2018-01-18 | 개시 | Credit Suisse | Neutral |
| 2017-09-05 | 재확인 | Evercore ISI | Outperform |
| 2017-08-17 | 개시 | Evercore ISI | Outperform |
| 2017-07-11 | 개시 | Robert W. Baird | Outperform |
| 2016-03-15 | 개시 | Stifel | Buy |
| 2015-11-09 | 다운그레이드 | UBS | Buy → Neutral |
| 2015-10-06 | 재확인 | H.C. Wainwright | Buy |
| 2015-06-09 | 개시 | Citigroup | Neutral |
| 2014-03-26 | 재확인 | HC Wainwright | Buy |
모두보기
Insmed Inc 주식(INSM)의 최신 뉴스
Insmed Insider Sold Shares Worth $2,199,915, According to a Recent SEC Filing - marketscreener.com
Schroder Investment Management Group Reduces Position in Insmed, Inc. $INSM - MarketBeat
Diametric Capital LP Purchases Shares of 7,757 Insmed, Inc. $INSM - MarketBeat
Will Insmed Incorporated (IM8N) stock outperform small cap peersJuly 2025 Selloffs & Expert-Curated Trade Recommendations - Newser
How Insmed Incorporated (IM8N) stock compares with tech leadersMarket Trend Review & Safe Capital Preservation Plans - Newser
Will Insmed Incorporated stock see PE expansionJuly 2025 Highlights & Reliable Breakout Forecasts - Newser
Insmed reports inducement grants under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
Rothschild & Co Redburn Initiates Coverage on Insmed With Buy Rating, $263 Price Target - marketscreener.com
Panagora Asset Management Inc. Sells 157,126 Shares of Insmed, Inc. $INSM - MarketBeat
Insmed (Nasdaq: INSM) approves 44,273 RSUs and 2,490 stock options for new hires - Stock Titan
Rothschild Redburn initiates Insmed stock with Buy rating, $263 target By Investing.com - Investing.com Canada
How Insmed Incorporated (IM8N) stock responds to job market shiftsOptions Play & Expert-Curated Trade Recommendations - Newser
Insmed Insider Sold Shares Worth $1,841,101, According to a Recent SEC Filing - marketscreener.com
Norges Bank Takes Position in Insmed, Inc. $INSM - MarketBeat
State Board of Administration of Florida Retirement System Has $13.10 Million Stake in Insmed, Inc. $INSM - MarketBeat
Can Insmed Incorporated stock double in next 5 yearsJuly 2025 Recap & Daily Price Action Insights - Newser
Insmed (NASDAQ:INSM) Reaches New 1-Year HighShould You Buy? - MarketBeat
Is Insmed Incorporated (IM8N) stock positioned for digital growth eraInsider Selling & Consistent Profit Alerts - Newser
Has Insmed’s 988% Three Year Surge Already Priced In Its Growth Story? - simplywall.st
How Insmed Incorporated (IM8N) stock valuation compares with sectorWeekly Earnings Recap & Verified Short-Term Plans - Newser
New York State Common Retirement Fund Buys 72,031 Shares of Insmed, Inc. $INSM - MarketBeat
Mizuho Maintains Insmed (INSM) Outperform Recommendation - Nasdaq
INSM: Mizuho Raises Price Target, Maintains Outperform Rating | INSM Stock News - GuruFocus
Mizuho Raises Price Target on Insmed to $256 From $196, Keeps Outperform Rating - marketscreener.com
Mizuho raises Insmed stock price target to $256 on improved outlook - Investing.com Canada
Neuberger Berman Group LLC Has $1.10 Million Stock Position in Insmed, Inc. $INSM - MarketBeat
Russell Investments Group Ltd. Cuts Holdings in Insmed, Inc. $INSM - MarketBeat
Insmed, Inc. $INSM Shares Sold by Groupama Asset Managment - MarketBeat
Insmed, Inc. $INSM Position Lowered by Elevation Point Wealth Partners LLC - MarketBeat
Loomis Sayles & Co. L P Decreases Stock Holdings in Insmed, Inc. $INSM - MarketBeat
Quadrature Capital Ltd Buys 89,217 Shares of Insmed, Inc. $INSM - MarketBeat
Insmed Insiders Sell US$54m Of Stock, Possibly Signalling Caution - Yahoo Finance
Northwest & Ethical Investments L.P. Has $488,000 Stock Holdings in Insmed, Inc. $INSM - MarketBeat
Why Insmed Incorporated stock appeals to analystsJuly 2025 Update & Entry Point Confirmation Signals - BỘ NỘI VỤ
F m Investments LLC Trims Stock Holdings in Insmed, Inc. $INSM - MarketBeat
30% of Billionaire Stanley Druckenmiller's Portfolio Is Invested in These 3 Biotech Stocks - The Motley Fool
Rhumbline Advisers Sells 95,212 Shares of Insmed, Inc. $INSM - MarketBeat
Insmed, Inc. $INSM Shares Acquired by Legal & General Group Plc - MarketBeat
Why Insmed Incorporated stock remains resilient2025 Major Catalysts & Smart Swing Trading Techniques - moha.gov.vn
Thornburg Investment Management Inc. Sells 15,592 Shares of Insmed, Inc. $INSM - MarketBeat
DNB Asset Management AS Buys New Stake in Insmed, Inc. $INSM - MarketBeat
Cetera Investment Advisers Purchases 10,783 Shares of Insmed, Inc. $INSM - MarketBeat
Charles Schwab Investment Management Inc. Sells 303,087 Shares of Insmed, Inc. $INSM - MarketBeat
Insmed, Inc. (NASDAQ:INSM) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Insmed (NASDAQ:INSM) Director Sells $1,022,900.00 in Stock - MarketBeat
Targets Report: How Insmed Incorporated (IM8N) stock correlates with oil markets2025 Biggest Moves & Technical Entry and Exit Tips - BỘ NỘI VỤ
Insmed (NASDAQ:INSM) Hits New 52-Week HighTime to Buy? - MarketBeat
Does Insmed Incorporated stock trade at a discount to peers2025 Short Interest & Low Drawdown Trading Strategies - BỘ NỘI VỤ
Insider Sell: Elizabeth Anderson Sells 5,000 Shares of Insmed In - GuruFocus
XTX Topco Ltd Has $5.67 Million Stock Position in Insmed, Inc. $INSM - MarketBeat
Is EU Approval of First NCFB Therapy Reframing Insmed’s (INSM) Investment Outlook? - Yahoo Finance
Insmed Inc (INSM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.53%
0.27%
자본화:
|
볼륨(24시간):